<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01123525</url>
  </required_header>
  <id_info>
    <org_study_id>AdCard 2010</org_study_id>
    <secondary_id>2008-004274-40</secondary_id>
    <nct_id>NCT01123525</nct_id>
  </id_info>
  <brief_title>Adenosine Cardioplegia; Improved Cardioprotection?</brief_title>
  <official_title>Adenosine Instead of Supranormal Potassium in Crystalloid Cardioplegia, a Randomized Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of North Norway</source>
  <brief_summary>
    <textblock>
      60 elective patients for CABG will be included to receive either standard hyperkalemic
      cardioplegia (St.Thomas Hospital Solution No I) or cardioplegia where supranormal potassium
      is replaced with 1.2 mM adenosine. Hypothesis as follows: 1. Adenosine instead of supranormal
      potassium in the cardioplegic solution give satisfactory cardiac arrest. 2. Adenosine instead
      of supranormal potassium in the cardioplegic solution gives equal cardioprotection. The
      patients will be followed with PiCCO-catheter to monitor cardiac function and repetitive
      blood samples to measure release of cardiac enzymes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Release of cardiac enzymes (TnT and CKMB)</measure>
    <time_frame>First 48 hour postoperatively</time_frame>
    <description>Repeatedly measured postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PiCCO</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>Measurement of cardiac function and hemodynamics the first 24 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial injury</measure>
    <time_frame>Peroperatively (before crossclamping aorta and after 5 minutes of reperfusion)</time_frame>
    <description>Measurements of markers of endothelial injury/dysfunction peroperatively. Blood will be sampled immediately before cross-clamping the aorta and after 5 minutes of reperfusion.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Angina Pectoris</condition>
  <arm_group>
    <arm_group_label>Adenosine cardioplegia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adenosine cardioplegia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard hyperkalemic cardioplegia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Adenosine</intervention_name>
    <description>1.2 mM adenosine instead of supranormal potassium in the cardioplegic solution</description>
    <arm_group_label>Adenosine cardioplegia</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective patients

          -  Ejection fraction &gt; 40%

          -  Age 40-75

          -  No release og TnT or CKMB within last week before CABG

          -  Pure CABG

        Exclusion Criteria:

          -  Age &gt;75 or &lt; 40

          -  EF &lt; 40%

          -  Emergency operations

          -  Unstable angina

          -  Release of TnT or CKMB within the week before operation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital of North Norway</name>
      <address>
        <city>Trooms√∏</city>
        <zip>9038</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2010</study_first_submitted>
  <study_first_submitted_qc>May 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2010</study_first_posted>
  <last_update_submitted>September 29, 2011</last_update_submitted>
  <last_update_submitted_qc>September 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina Pectoris</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenosine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

